🇺🇸 FDA
Company

Tango

Tango Therapeutics

TNGX pharma USA

Quick answer

Tango is a pharma company (TNGX) headquartered in BOSTON, MA, USA with 6 tracked pipeline programs.

Pipeline (6)

project

S095035

MTAP-deleted Solid Tumors

Phase 2 · small_molecule · active

1 trials project

TNG260

Non Small Cell Lung Cancer

Phase 2 · small_molecule · active

1 trials project

TNG348

Breast Cancer

Phase 2 · small_molecule · terminated

1 trials project

TNG456

Non Small Cell Lung Cancer

Phase 2 · small_molecule · active

1 trials project

TNG462

Locally Advanced Solid Tumor

Phase 2 · small_molecule · active

1 trials project

TNG908

Locally Advanced Solid Tumor

Phase 2 · small_molecule · terminated

1 trials

Patents (8)

patent

US 12403137

Compounds and methods of use

Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12304907

Compounds and methods of use

Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12264154

Compounds and methods of use

Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12043607

HDAC inhibitors and therapeutic use thereof

Expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11999727

Compounds and methods of use

Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11986471

Compounds and methods of use

Expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11492350

Compounds and methods of use

Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11077101

Compounds and methods of use

Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)